Friday, June 26, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 785 of 1,261
  1. US 8871918

    Multiple exon skipping compositions for DMD

    Sarepta Therapeutics, Inc. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  2. US 8871904

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  3. US 8871906

    Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  4. US 8871907

    Glycosylated immunoglobulin and immunoadhesin comprising the same

    KOREA PRIME PHARM CO., LTD. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  5. US 8871789

    Method of preventing or treating viral infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  6. US 8871774

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  7. US 8871766

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  8. US 8871447

    Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence

    The Regents of the University of California · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  9. US 8871905

    Modification of CXCR4 using engineered zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  10. US 8871487

    Compositions, methods and uses for inducing viral growth

    Takeda Vaccines, Inc. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  11. US 8871925

    Compositions of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  12. EP 2791134

    CHEMISCHE VERBINDUNG ALS ZWISCHENPRODUKT ZUR HERSTELLUNG EINES CATECHOL-O-METHYLTRANSFERASE-INHIBITORS

    BIAL PORTELA & Cª S A [PT] · Granted Oct 22, 2014 · Expires Oct 17, 2034

    granted
  13. US 8865741

    Aminoindane compounds and use thereof in treating pain

    Asana BioSciences, LLC · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  14. US 8865187

    Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity

    The Board of Regents of the University of Texas System · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  15. US 8865686

    Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  16. US 8865745

    Pyrazolone derivatives as PDE4 inhibitors

    TAKEDA GMBH · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  17. US 8865461

    Rabies virus vector systems and compositions and methods thereof

    The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  18. US 8865717

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  19. US 8865469

    Methods of transforming a Listeria

    The Regents of the University of California · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  20. US 8865748

    Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer

    Akebia Therapeutics, Inc. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  21. US 8865723

    Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury

    Tetra Discovery Partners · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  22. US 8865728

    Combinations comprising methotrexate and DHODH inhibitors

    Almirall, S.A. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  23. US 8865722

    Wet formulations of aripiprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  24. US 8865694

    Topical compositions for treatment of skin conditions

    Molecular Design International, Inc. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.